Home > Financial Ratios > BIOCON

BIOCON
Core EBITDA Margin

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 19.6821.4118.8018.1818.23

What is the latest Core EBITDA Margin ratio of BIOCON ?

The latest Core EBITDA Margin ratio of BIOCON is 19.68 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202519.68
Mar202421.41
Mar202318.80
Mar202218.18
Mar202118.23

How is Core EBITDA Margin of BIOCON Trending?

Years Core EBITDA Margin % Change
Mar2025 19.68
-8.08
Mar2024 21.41
13.88
Mar2023 18.8
3.41
Mar2022 18.18
-0.27
Mar2021 18.23 -

Other Financial Ratios of BIOCON


Compare Core EBITDA Margin ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹45,905.9 Cr -10.2% -7.8% 5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,702.0 Cr -3.3% -4.6% -7.9% Stock Analytics
DIVIS LABORATORIES ₹156,908.0 Cr -9% -13.6% 24% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,896.0 Cr -1.1% 7% 8.2% Stock Analytics
CIPLA ₹119,988.0 Cr -2% 0.6% -4% Stock Analytics
DR REDDYS LABORATORIES ₹101,122.0 Cr -1.1% -3.8% -13.3% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-10.2%

-7.8%

5.1%

SENSEX

-0.9%

-4.4%

1.6%


You may also like the below Video Courses